1. In Vivo
  2. >>Market Access

Ukraine War Puts The Pharmaceutical Industry To The Test

 
• By Thomas Dobmeyer

Pharmaceutical leaders are responding to the many and varied challenges arising from the war in Ukraine.  

Ukraine

The war in Ukraine has been a test for the pharmaceutical industry, but one that senior leadership have responded to with compassion as well as censure. Many companies are providing financial donations and medical supplies and have pledged to work to address the health needs of everyone affected by the war.

At the same time, more than 400 biopharma leaders signed an open letter condemning the attack, calling for “economic disengagement”...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from In Vivo

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

 
• By Anabel Costa-Ferreira

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

Behind The Buyout: Dispatches From The Dealmaking Table

 
• By Jo Shorthouse

In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.

Crisis Or Opportunity? US MFN Policy Could Test Japan’s Appetite For Reforms

 
• By Lisa Takagi

While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.